drugset
drugset / Trial / NCT04301934

Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection

NCT04301934 ↗

Completed 12 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized controlled trial to determine clinical and microbiome difference between fractional CO2 Laser and vaginal estrogen in treating patients with recurrent urinary tract infection (UTI).

Timeline

Start
2020-06-01
Primary completion
2023-04-30
Completion
2023-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 1 g Other
Comparator conjugated estrogens Other / unclassified 0.5 g Other

Indications

urinary tract infection